跳至主要内容
临床试验/NCT06907992
NCT06907992尚未招募不适用

Short-Course Antifungal Therapy vs Standard of Care (14 Day Therapy) for Uncomplicated Candidemia (SCAT)

Augusta University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年5月1日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
试验地点
1
主要终点
Eradication of candida from the blood at day 7 or day 14

研究概览

简要总结

The goal of this clinical trial is to assess whether a seven-day course of standard of care (echinocandin) antifungal therapy is non-inferior to a 14-day course of echinocandin antifungal therapy in patients with uncomplicated candidemia in terms of clinical, mycologic, adverse events and all cause mortality.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients ≥ 18 years of age
  • Uncomplicated candidemia (positive blood culture only). No evidence of invasive candidiasis at day 1 or until day
  • Received < 5 days of prior antifungal therapy
  • Informed Consent for randomization
  • Patients that did not consent to randomization have consented to be used as a natural history (controls) and will allow collection of available data from the medical record.

排除标准

  • Inadequate source control (e.g., unable to remove endovascular devices, urinary catheters).
  • Invasive candidiasis of any type (e.g., deep seated candidiasis from sources other than blood)
  • Abnormal LFTs > 10-fold
  • Greater than 5 days of prior antifungal therapy
  • Endovascular devices that cannot be removed.
  • Immunocompromised patients (AIDS/HIV; solid organ transplant, bone marrow transplant patients, oncology patients receiving chemotherapy, neutropenic patients (ANC of < 1,500 cells/L
  • Neutropenic at time of consent (what does this mean)
  • Break-through candidemia (people with prior candidemia who relapsed) after treatment with antifungal therapy)
  • Unable to provide informed consent from either the patient or legally authorized authority (LAR)
  • Expected mortality within 96 hours

研究组 & 干预措施

7 Days

Study participants randomized to the 7 Day group will receive the short-course antifungal therapy for 7 days.

干预措施: Antifungal treatment (Drug)

14 Days

Study participants randomized to the 14 Day group will receive the standard of care antifungal therapy for 14 days.

干预措施: Antifungal treatment (Drug)

结局指标

主要结局

Eradication of candida from the blood at day 7 or day 14

时间窗: 14 Days

Blood culture monitoring at day 7 and day 14

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jose Vazquez

Principal Investigator

Augusta University

研究点 (1)

Loading locations...

相似试验